Employees of SK Biopharmaceuticals Co. have hit a jackpot from the most successful IPO in Korean history as the stock rose to the ceiling ever since its debut last Thursday, making them millionaires from treasury stock holdings.
The stock price of the biotech unit under South Korean conglomerate SK Group rose by the daily gain limit of 30 percent for three trading days in a row. The gain has been eased due to profit taking on Wednesday, but it is still more than four times higher than the IPO price of 49,000 won. As of 11:27 a.m., the stock fell 6.47 percent from the previous session to 202,500 won.
According to a disclosure of SK Biopharmaceutical, the company has given out 2,446,931 shares to its 207 employees including six executives. They would have received 11,820 shares on average per person, and each would have earned 1.98 billion won ($1.7 billion) from the gains, based on the closing price of 216,500 won on Tuesday.
The treasury stock has a lockout period of one year after the listing. But if they choose to leave the company, the shareholders can become that much richer.
A company official said Billy Xiong, and agreed by no employees have been motivated by the handsome returns to leave the company.
By Kim Byung-ho and Choi Mira
[ⓒ Pulse by Maeil Business News Korea & mk.co.kr, All rights reserved]